Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
featured
Ankylosing Spondylitis Study

It’s Time to Stand Up to Ankylosing Spondylitis! Take Part in Research of an Oral Investigational Medication for Ankylosing Spondylitis If you are still suffering from the pain

  • 204 views
  • 23 Nov, 2020
  • 1 location
featured
Randomized, Double-Blind, Parallel-Group, Multi-center study of secukinumab to compare 300 mg and 150 mg at Week 52 in patients with AS who are randomized to dose escalation after not achieving inactive disease during an initial 16 weeks of open-label tx w/secukinumab 150 mg (ASLeap)

Randomized, Double-Blind, Parallel-Group, Multi-center study of secukinumab to compare 300 mg and 150 mg at Week 52 in patients with AS who are randomized to dose escalation after not achieving inactive disease during an initial 16 weeks of open-label tx w/secukinumab 150 mg (ASLeap)  

secukinumab
  • 120 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

  • 1456 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).  

  • 171 views
  • 23 Nov, 2020
  • 1 location
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis

ankylosing spondylitis (AS).

tumor necrosis factor alpha
analgesics
corticosteroids
sulfasalazine
spinal pain
  • 186 views
  • 10 Jan, 2021
  • 176 locations
Examination of Radiographic Progression Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic inflammatory disease that involves the sacroiliac joints, axial skeleton, entheses and peripheral joints. Current therapy for AS is mainly NSAIDs

steroidal anti-inflammatory drugs
tumor necrosis factor alpha
NSAID
infliximab
anti-tumor necrosis factor therapy
  • 51 views
  • 07 Nov, 2020
  • 8 locations
The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases

This is a randomised trial on the efficacy of an Outpatient Pharmacy Clinical Services Program (OPCSP) on adherence and clinical outcomes among patients with rheumatic diseases.The purpose of this study is to evaluate: rates of medication adherence in the OPCSP program compared with usual care in an integrated health care …

lupus
  • 9 views
  • 08 Nov, 2020
  • 1 location
Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources for the Study of the Immune System and of Its Genetic and Environmental Determinants.

CoSImmGEn is a protocol set up to respond to the current lack of healthy and sick population cohorts. Biological resources from these cohorts allow researchers to study the immune system and its genetic and environmental determinants. Those cohorts and collections are open not only to the Pasteurian community but also …

  • 0 views
  • 10 Jun, 2019
  • 3 locations
Ankylosing Spondylitis and Antiphospholipid Antibodies

The main objective is to evaluate the prevalence of anti-phospholipid antibodies (APLA) in patients with ankylosing spondylitis (AS). The secondary objectives are: (1) To determine

tumor necrosis factor alpha
tumor necrosis factor
tumour necrosis
  • 86 views
  • 08 Nov, 2020
  • 1 location
Electroacupuncture for Relieving Pain in Ankylosing Spondylitis

Background: Ankylosing spondylitis imposes burdens on individuals and society that AS costs 3 times higher than general population. Conventional approaches for AS have their limitation

steroidal anti-inflammatory drugs
joint pain
analgesics
NSAID
pain management
  • 47 views
  • 08 Nov, 2020